- Home
- PAYC vs RGC Comparison
PAYC vs RGC Comparison
Compare PAYC & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAYC | RGC |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 9.8B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PAYC | RGC |
|---|---|---|
| Price | $163.46 | $19.62 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $223.08 | N/A |
| AVG Volume (30 Days) | ★ 815.6K | 238.7K |
| Earning Date | 11-05-2025 | 10-24-2025 |
| Dividend Yield | ★ 0.92% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.05 | N/A |
| Revenue | ★ $2,001,300,000.00 | N/A |
| Revenue This Year | $11.03 | N/A |
| Revenue Next Year | $8.85 | N/A |
| P/E Ratio | $20.22 | ★ N/A |
| Revenue Growth | ★ 9.72 | N/A |
| 52 Week Low | $156.50 | $0.09 |
| 52 Week High | $267.76 | $83.60 |
Technical Indicators
Market Signals| Indicator | PAYC | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 42.64 | 72.64 |
| Support Level | $160.30 | $16.30 |
| Resistance Level | $170.22 | $18.10 |
| Average True Range (ATR) | 3.86 | 1.72 |
| MACD | 1.17 | 0.53 |
| Stochastic Oscillator | 30.75 | 98.55 |
Price Performance
Historical ComparisonAbout PAYC Paycom Software Inc.
Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.